Black Rock Inc. Compugen LTD Transaction History

Black Rock Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.66 - $2.32 $12,022 - $42,261	-18,216 Reduced 2.83%	625,801 $411,000
Q2 2022 Aug 12, 2022	SELL	$1.57 - $3.33 $2.6 Million - $5.51 Million	-1,655,423 Reduced 71.99%	644,017 $1.19 Million
Q1 2022 May 12, 2022	BUY	$2.76 - $4.64 $1,368 - $2,301	496 Added 0.02%	2,299,440 $7.4 Million
Q4 2021 Feb 10, 2022	SELL	$4.09 - $7.16 $980,610 - $1.72 Million	-239,758 Reduced 9.44%	2,298,944 $9.89 Million
Q3 2021 Nov 09, 2021	BUY	$5.8 - $8.02 $931,033 - $1.29 Million	160,523 Added 6.75%	2,538,702 $15.2 Million
Q2 2021 Aug 11, 2021	BUY	$6.87 - $9.16 $16.3 Million - $21.8 Million	2,378,179 New	2,378,179 $19.7 Million

13.1M

79.2K

12.7K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $131M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.